APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transforming Growth Factor Beta 1

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Selected research

Industry Growth & Trends

Global Transforming Growth Factor Beta 1 Industry Growth and Trends Forecast to 2032

Report ID 174042720121 December 2025106 pages

Choose your research edition.

Industry ResearchTransforming Growth Factor Beta 1 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Transforming Growth Factor Beta 1 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transforming Growth Factor Beta 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transforming Growth Factor Beta 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Transforming Growth Factor Beta 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transforming Growth Factor Beta 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transforming Growth Factor Beta 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transforming Growth Factor Beta 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transforming Growth Factor Beta 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transforming Growth Factor Beta 1 Market by Company

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Transforming Growth Factor Beta 1 Segment by Type

Pirfenidone

Galunisertib

Others

Transforming Growth Factor Beta 1 Segment by Application

IPF

Cancer

Others

Transforming Growth Factor Beta 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pirfenidone Table 2. Major Company of Galunisertib Table 3. Major Company of Others Table 4. Global Transforming Growth Factor Beta 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 6. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type (2021-2026) Table 7. Global Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 8. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Type (2021-2026) Table 9. Global Transforming Growth Factor Beta 1 Price by Type (2021-2026) & (USD/Unit) Table 10. Global Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 11. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type (2027-2032) Table 12. Global Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (US$ Million) Table 13. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Type (2027-2032) Table 14. Global Transforming Growth Factor Beta 1 Price by Type (2027-2032) & (USD/Unit) Table 15. North America Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 16. North America Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 18. Europe Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 22. Latin America Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (US$ Million) Table 25. Transforming Growth Factor Beta 1 Industry Trends Table 26. Transforming Growth Factor Beta 1 Industry Drivers Table 27. Transforming Growth Factor Beta 1 Industry Opportunities and Challenges Table 28. Transforming Growth Factor Beta 1 Industry Restraints Table 29. Global Transforming Growth Factor Beta 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2021-2026) Table 31. Global Transforming Growth Factor Beta 1 Sales by Company (2021-2026) & (K Units) Table 32. Global Transforming Growth Factor Beta 1 Sales Share by Company (2021-2026) Table 33. Global Transforming Growth Factor Beta 1 Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Transforming Growth Factor Beta 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Transforming Growth Factor Beta 1 Major Company Production Sites and Headquarters Table 36. Global Transforming Growth Factor Beta 1 Company, Product Type & Application Table 37. Global Transforming Growth Factor Beta 1 Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Transforming Growth Factor Beta 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026) & (K Units) Table 42. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Region (2021-2026) Table 43. Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026) & (US$ Million) Table 44. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Region (2021-2026) Table 45. Global Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032) & (K Units) Table 47. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Region (2027-2032) Table 48. Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032) & (US$ Million) Table 49. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Region (2027-2032) Table 50. Global Transforming Growth Factor Beta 1 Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Transforming Growth Factor Beta 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 53. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application (2021-2026) Table 54. Global Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 55. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Application (2021-2026) Table 56. Global Transforming Growth Factor Beta 1 Price by Application (2021-2026) & (USD/Unit) Table 57. Global Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 58. Global Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application (2027-2032) Table 59. Global Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (US$ Million) Table 60. Global Transforming Growth Factor Beta 1 Sales Market Share in Value by Application (2027-2032) Table 61. Global Transforming Growth Factor Beta 1 Price by Application (2027-2032) & (USD/Unit) Table 62. North America Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 63. North America Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 65. Europe Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 69. Latin America Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (US$ Million) Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Roche Transforming Growth Factor Beta 1 Product Portfolio Table 76. Roche Recent Development Table 77. Shionogi Ltd Company Information Table 78. Shionogi Ltd Business Overview Table 79. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio Table 81. Shionogi Ltd Recent Development Table 82. Acceleron Pharma Inc Company Information Table 83. Acceleron Pharma Inc Business Overview Table 84. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio Table 86. Acceleron Pharma Inc Recent Development Table 87. Genzyme Corp Company Information Table 88. Genzyme Corp Business Overview Table 89. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio Table 91. Genzyme Corp Recent Development Table 92. Isarna Therapeutics GmbH Company Information Table 93. Isarna Therapeutics GmbH Business Overview Table 94. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio Table 96. Isarna Therapeutics GmbH Recent Development Table 97. Scholar Rock Company Information Table 98. Scholar Rock Business Overview Table 99. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio Table 101. Scholar Rock Recent Development Table 102. Sirnaomics Inc Company Information Table 103. Sirnaomics Inc Business Overview Table 104. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 106. Sirnaomics Inc Recent Development Table 107. Eli Lilly and Co Company Information Table 108. Eli Lilly and Co Business Overview Table 109. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio Table 111. Eli Lilly and Co Recent Development Table 112. Formation Biologics Inc Company Information Table 113. Formation Biologics Inc Business Overview Table 114. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 116. Formation Biologics Inc Recent Development Table 117. Novartis AG Company Information Table 118. Novartis AG Business Overview Table 119. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Novartis AG Transforming Growth Factor Beta 1 Product Portfolio Table 121. Novartis AG Recent Development Table 122. North America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 124. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 125. North America Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Transforming Growth Factor Beta 1 Sales Market Share Forecast by Country (2027-2032) Table 127. North America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Transforming Growth Factor Beta 1 Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Transforming Growth Factor Beta 1 Market Share by Country (2021-2026) Table 130. North America Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Transforming Growth Factor Beta 1 Market Share Forecast by Country (2027-2032) Table 132. Europe Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 134. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 135. Europe Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Transforming Growth Factor Beta 1 Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Transforming Growth Factor Beta 1 Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Transforming Growth Factor Beta 1 Market Share by Country (2021-2026) Table 140. Europe Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Transforming Growth Factor Beta 1 Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Transforming Growth Factor Beta 1 Market Share by Country (2021-2026) Table 150. Asia-Pacific Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Transforming Growth Factor Beta 1 Market Share Forecast by Country (2027-2032) Table 152. Latin America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 154. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 155. Latin America Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Transforming Growth Factor Beta 1 Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Transforming Growth Factor Beta 1 Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Transforming Growth Factor Beta 1 Market Share by Country (2021-2026) Table 160. Latin America Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Transforming Growth Factor Beta 1 Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Transforming Growth Factor Beta 1 Market Share by Country (2021-2026) Table 170. Middle East and Africa Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Transforming Growth Factor Beta 1 Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Transforming Growth Factor Beta 1 Distributors List Table 175. Transforming Growth Factor Beta 1 Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Transforming Growth Factor Beta 1 Image Figure 2. Global Transforming Growth Factor Beta 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transforming Growth Factor Beta 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Transforming Growth Factor Beta 1 Sales (2021-2032) & (K Units) Figure 5. Pirfenidone Image Figure 6. Global Pirfenidone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Galunisertib Image Figure 8. Global Galunisertib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Transforming Growth Factor Beta 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Transforming Growth Factor Beta 1 Market Share by Type 2025 VS 2032 Figure 13. North America Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type in 2025 Figure 14. North America Transforming Growth Factor Beta 1 Sales Market Share in Value by Type in 2025 Figure 15. Europe Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type in 2025 Figure 16. Europe Transforming Growth Factor Beta 1 Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share in Value by Type in 2025 Figure 19. Latin America Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Transforming Growth Factor Beta 1 Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. IPF Image Figure 26. Global IPF Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cancer Image Figure 28. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Transforming Growth Factor Beta 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Transforming Growth Factor Beta 1 Market Share by Application 2025 VS 2032 Figure 33. North America Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application in 2025 Figure 34. North America Transforming Growth Factor Beta 1 Sales Market Share in Value by Application in 2025 Figure 35. Europe Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application in 2025 Figure 36. Europe Transforming Growth Factor Beta 1 Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share in Value by Application in 2025 Figure 39. Latin America Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Transforming Growth Factor Beta 1 Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share in Value by Application in 2025 Figure 43. North America Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Transforming Growth Factor Beta 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Transforming Growth Factor Beta 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Transforming Growth Factor Beta 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Transforming Growth Factor Beta 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Transforming Growth Factor Beta 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Transforming Growth Factor Beta 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Transforming Growth Factor Beta 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Transforming Growth Factor Beta 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Transforming Growth Factor Beta 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Transforming Growth Factor Beta 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Transforming Growth Factor Beta 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Transforming Growth Factor Beta 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Transforming Growth Factor Beta 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Transforming Growth Factor Beta 1 Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Transforming Growth Factor Beta 1 Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pirfenidone
  • Galunisertib
  • Others
Applications
  • IPF
  • Cancer
  • Others
Companies covered
  • Roche
  • Shionogi Ltd
  • Acceleron Pharma Inc
  • Genzyme Corp
  • Isarna Therapeutics GmbH
  • Scholar Rock
  • Sirnaomics Inc
  • Eli Lilly and Co
  • Formation Biologics Inc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transforming Growth Factor Beta 1 Market by Type
  6. 1.3.1 Pirfenidone
  7. 1.3.2 Galunisertib
  8. 1.3.3 Others
  9. 1.4 Global Transforming Growth Factor Beta 1 Market Size by Type
  10. 1.4.1 Global Transforming Growth Factor Beta 1 Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Transforming Growth Factor Beta 1 Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Transforming Growth Factor Beta 1 Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Transforming Growth Factor Beta 1 Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Transforming Growth Factor Beta 1 Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Transforming Growth Factor Beta 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Transforming Growth Factor Beta 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transforming Growth Factor Beta 1 Industry Trends
  2. 2.2 Transforming Growth Factor Beta 1 Industry Drivers
  3. 2.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
  4. 2.4 Transforming Growth Factor Beta 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transforming Growth Factor Beta 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Transforming Growth Factor Beta 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Transforming Growth Factor Beta 1 Price (2021-2026)
  4. 3.4 Global Transforming Growth Factor Beta 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transforming Growth Factor Beta 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Transforming Growth Factor Beta 1 Company, Product Type & Application
  7. 3.7 Global Transforming Growth Factor Beta 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transforming Growth Factor Beta 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transforming Growth Factor Beta 1 Tier 1, Tier 2, and Tier 3
4 Transforming Growth Factor Beta 1 Regional Status and Outlook
  1. 4.1 Global Transforming Growth Factor Beta 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transforming Growth Factor Beta 1 Historic Market Size by Region
  3. 4.2.1 Global Transforming Growth Factor Beta 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transforming Growth Factor Beta 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transforming Growth Factor Beta 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transforming Growth Factor Beta 1 Forecasted Market Size by Region
  7. 4.3.1 Global Transforming Growth Factor Beta 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transforming Growth Factor Beta 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transforming Growth Factor Beta 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transforming Growth Factor Beta 1 by Application
  1. 5.1 Transforming Growth Factor Beta 1 Market by Application
  2. 5.1.1 IPF
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Transforming Growth Factor Beta 1 Market Size by Application
  6. 5.2.1 Global Transforming Growth Factor Beta 1 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Transforming Growth Factor Beta 1 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Transforming Growth Factor Beta 1 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Transforming Growth Factor Beta 1 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Transforming Growth Factor Beta 1 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Transforming Growth Factor Beta 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Transforming Growth Factor Beta 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Shionogi Ltd
  8. 6.2.1 Shionogi Ltd Company Information
  9. 6.2.2 Shionogi Ltd Business Overview
  10. 6.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
  12. 6.2.5 Shionogi Ltd Recent Developments
  13. 6.3 Acceleron Pharma Inc
  14. 6.3.1 Acceleron Pharma Inc Company Information
  15. 6.3.2 Acceleron Pharma Inc Business Overview
  16. 6.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
  18. 6.3.5 Acceleron Pharma Inc Recent Developments
  19. 6.4 Genzyme Corp
  20. 6.4.1 Genzyme Corp Company Information
  21. 6.4.2 Genzyme Corp Business Overview
  22. 6.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
  24. 6.4.5 Genzyme Corp Recent Developments
  25. 6.5 Isarna Therapeutics GmbH
  26. 6.5.1 Isarna Therapeutics GmbH Company Information
  27. 6.5.2 Isarna Therapeutics GmbH Business Overview
  28. 6.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
  30. 6.5.5 Isarna Therapeutics GmbH Recent Developments
  31. 6.6 Scholar Rock
  32. 6.6.1 Scholar Rock Company Information
  33. 6.6.2 Scholar Rock Business Overview
  34. 6.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
  36. 6.6.5 Scholar Rock Recent Developments
  37. 6.7 Sirnaomics Inc
  38. 6.7.1 Sirnaomics Inc Company Information
  39. 6.7.2 Sirnaomics Inc Business Overview
  40. 6.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
  42. 6.7.5 Sirnaomics Inc Recent Developments
  43. 6.8 Eli Lilly and Co
  44. 6.8.1 Eli Lilly and Co Company Information
  45. 6.8.2 Eli Lilly and Co Business Overview
  46. 6.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
  48. 6.8.5 Eli Lilly and Co Recent Developments
  49. 6.9 Formation Biologics Inc
  50. 6.9.1 Formation Biologics Inc Company Information
  51. 6.9.2 Formation Biologics Inc Business Overview
  52. 6.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
  54. 6.9.5 Formation Biologics Inc Recent Developments
  55. 6.10 Novartis AG
  56. 6.10.1 Novartis AG Company Information
  57. 6.10.2 Novartis AG Business Overview
  58. 6.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
  60. 6.10.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America Transforming Growth Factor Beta 1 Sales by Country
  2. 7.1.1 North America Transforming Growth Factor Beta 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transforming Growth Factor Beta 1 Market Size by Country
  6. 7.2.1 North America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transforming Growth Factor Beta 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transforming Growth Factor Beta 1 Sales by Country
  2. 8.1.1 Europe Transforming Growth Factor Beta 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transforming Growth Factor Beta 1 Market Size by Country
  6. 8.2.1 Europe Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transforming Growth Factor Beta 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Country
  2. 9.1.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transforming Growth Factor Beta 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transforming Growth Factor Beta 1 Sales by Country
  2. 10.1.1 South America Transforming Growth Factor Beta 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transforming Growth Factor Beta 1 Market Size by Country
  6. 10.2.1 South America Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transforming Growth Factor Beta 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country
  2. 11.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transforming Growth Factor Beta 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transforming Growth Factor Beta 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transforming Growth Factor Beta 1 Value Chain Analysis
  2. 12.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transforming Growth Factor Beta 1 Production Mode & Process
  7. 12.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transforming Growth Factor Beta 1 Distributors
  10. 12.2.3 Transforming Growth Factor Beta 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst